Brief: Essa Pharma Inc - Epi-8207 Shows Robust Potency Degrading Ar, Including Ar Splice Variants And Clinically Relevant Ar Mutants
26/10/2022 21:40
Oct 26 (Reuters) - ESSA Pharma Inc EPIX.O :
* ESSA PHARMA INC - EPI-8207 SHOWS ROBUST POTENCY DEGRADING
AR,
INCLUDING AR SPLICE VARIANTS AND CLINICALLY RELEVANT AR MUTANTS
Source text for Eikon: ID:nCNWWJxhva
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics